Full-Time

IT Executive Director / VP

Confirmed live in the last 24 hours

Fractyl Health

Fractyl Health

51-200 employees

Therapies for Type 2 Diabetes treatment

Biotechnology
Healthcare

Expert

Burlington, MA, USA

No regular travel required.

Category
Cybersecurity
IT Project Management
IT & Security
Requirements
  • Bachelor's degree in Information Technology, Information Systems, Computer Science, Software Engineering, Cyber Security, or related field preferred.
  • MS in a related field is a plus.
  • Minimum of 12+ years of experience in IT management.
  • Applicable experience in biotech, pharmaceutical and/or medical device industries preferred.
  • Proficiency with modern digital tools related to IT management.
  • Strong understanding of challenges and requirements of technology in the biotech industry including data security, compliance, and scalability.
  • Strong understanding of data security and associated regulations.
  • Project-management, decision-making, and leadership attributes are a must.
  • Excellent communication skills.
Responsibilities
  • Develop and implement procedures around Fractyl’s IT assets including, but not limited to, systems access, computers, telecommunications, software, and security.
  • Oversee the design, implementation, and maintenance of infrastructure, platforms, and services.
  • Establish and maintain relationships with vendors and strategic partners, ensuring effective collaboration and leveraging their expertise for successful implementation and support.
  • Execute asset protection through encryption and traffic management.
  • Coordination of software solutions specific to regulations for both medical devices and biologics.
  • Offer strategic support to Fractyl’s stakeholders, develop solution plans, and drive implementation.
  • Manage the IT Help Desk to ensure timely response to employee tickets.
  • Perform all activities in compliance with applicable regulations, Fractyl’s policies and guidelines, including, but not limited to, timely documentation of activities and maintaining all required applicable training.
  • Bring a 'can do' spirit to work and deliver on other responsibilities as assigned.

Fractyl focuses on creating therapies for Type 2 Diabetes (T2D) and obesity, targeting the root causes of these metabolic diseases. Their main product, Rejuva, is a gene therapy designed to enhance the function of islet cells in the pancreas, which are essential for blood sugar regulation. By improving these cells, Fractyl aims to help patients achieve long-term remission from T2D and obesity. Currently, Rejuva is in preclinical development and has received a CE mark for commercial availability in Europe, although it is still awaiting full FDA approval. Unlike many competitors, Fractyl's approach centers on addressing the underlying mechanisms of these diseases rather than just managing symptoms. The company's goal is to transform the treatment landscape for T2D and obesity, ultimately preventing and eliminating these conditions.

Company Stage

IPO

Total Funding

$282.2M

Headquarters

Lexington, Kentucky

Founded

2010

Growth & Insights
Headcount

6 month growth

1%

1 year growth

22%

2 year growth

23%
Simplify Jobs

Simplify's Take

What believers are saying

  • Fractyl's innovative approach to metabolic diseases could revolutionize treatment paradigms, offering significant career growth opportunities in a pioneering field.
  • The appointment of experienced leaders like Adrian Kimber and Dr. Timothy Kieffer strengthens the company's strategic and scientific capabilities, enhancing its market positioning.
  • Successful IPO and promising preclinical results for Rejuva indicate strong financial backing and potential for substantial market impact.

What critics are saying

  • The success of Fractyl Health is heavily dependent on the regulatory approval and commercial adoption of its therapies, which are still in preclinical or early clinical stages.
  • The competitive landscape for diabetes and obesity treatments is intense, with numerous established players and emerging startups vying for market share.

What makes Fractyl Health unique

  • Fractyl Health focuses on gene therapy for Type 2 Diabetes and obesity, targeting the root causes of these diseases, unlike many competitors who focus on symptom management.
  • Their flagship product, Rejuva, aims to enhance pancreatic islet cell function, offering a potential long-term remission solution for T2D and obesity.
  • The company has achieved a CE mark for Rejuva, indicating compliance with stringent health and safety standards in the European Economic Area, setting it apart from competitors still in investigational stages.

Help us improve and share your feedback! Did you find this helpful?